BioCentury | Jan 18, 2010
Company News

Boulder Diagnostics Inc., Multimmune deal

...elevated Hsp70 levels with the presence of the tumor specific Hsp70 cell surface marker. Multimmune's Enkastim-ev...
BioCentury | Oct 15, 2009
Distillery Therapeutics

Indication: Cancer

...Next steps include additional preclinical studies to confirm the function of the inhibitors. Multimmune GmbH's Enkastim...
Items per page:
1 - 2 of 2